0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Endoscopic Retrograde Cholangiopancreatography Market by Procedure Type (Diagnostic, Therapeutic), Product (Accessories, Endoscope Systems, Imaging Systems), Application, End User - Global Forecast 2025-2030- Product Image
Endoscopic Retrograde Cholangiopancreatography Market by Procedure Type (Diagnostic, Therapeutic), Product (Accessories, Endoscope Systems, Imaging Systems), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Endoscopic Retrograde Cholangiopancreatography Market by Procedure Type (Diagnostic, Therapeutic), Product (Accessories, Endoscope Systems, Imaging Systems), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674534
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Endoscopic Retrograde Cholangiopancreatography (ERCP) market is experiencing a decisive transformation as innovation and procedural integration redefine its value within modern gastroenterology. As medical centers prioritize efficiency, safety, and precision, ERCP’s dual diagnostic and therapeutic strengths are capturing attention at the highest organizational levels.

Market Snapshot: Trends and Growth Overview in the Endoscopic Retrograde Cholangiopancreatography Market

The Endoscopic Retrograde Cholangiopancreatography market expanded from USD 2.05 billion in 2024 to USD 2.21 billion in 2025. Sustained by a CAGR of 7.67%, the sector is forecasted to reach USD 3.20 billion by 2030. Growth is underpinned by rising demand for minimally invasive interventions, an expanding base of biliary and pancreatic disease cases, and the continuous upgrade cycle for imaging and accessory systems. Newer platforms are being rapidly adopted in both hospital and outpatient settings as care providers seek reliable, safer, and more cost-effective alternatives to open surgery. Technology-led differentiation, procedural consolidation, and supportive reimbursement frameworks are further catalyzing adoption across key regions.

Scope & Segmentation: Breadth of Analysis in ERCP Solutions and Stakeholders

This comprehensive study segments the market according to procedure, product, clinical application, end user, and geographic distribution. The analysis provides high-resolution insights essential for business and procurement leaders.

  • Procedure Types: Diagnostic (including cholangiography and pancreatography), Therapeutic (such as sphincterotomy, stent placement, and stone extraction).
  • Products: Accessories, Endoscope Systems, Imaging Systems (including light sources and video processors).
  • Applications: Biliary System Disorders (gallstones, leaks, strictures), Pancreatic System Disorders (pancreatitis, tumors).
  • End Users: Ambulatory Surgical Centers, Hospitals, Specialty Clinics.
  • Geographic Regions: Americas (including targeted US states, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (covering major and emerging markets), Asia-Pacific (China, India, Japan, Australia, among others).
  • Key Industry Players: Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Fujifilm Holdings Corporation, HOYA Corporation, KARL STORZ SE & Co. KG, Cook Medical LLC, CONMED Corporation, Ambu A/S, Stryker Corporation.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • ERCP is evolving from a niche diagnostic tool into a mainstream, integrated therapeutic platform delivering high value in multidisciplinary care pathways.
  • Technological advancements, including digital imaging, minimally invasive accessories, and AI-enabled analytics, are enhancing both safety and efficiency in procedure delivery.
  • Standardization of clinical training and credentialing is reducing variability and broadening access, supporting best practice diffusion from large academic hospitals to community environments.
  • Portable, cloud-integrated, and modular device designs enable flexibility for both high-volume centers and distributed outpatient locations, addressing growing procedural demand and shifting care paradigms.
  • Supply chain realignments, including regional manufacturing and smart inventory management, are actively safeguarding cost stability amid new international tariffs.
  • Vendor strategies increasingly emphasize collaborative innovation with software partners and distributors, driving the development of ergonomic, data-driven product portfolios that meet evolving customer requirements.

Tariff Impact: Adapting to Supply Chain and Cost Pressures

The introduction of United States tariffs in 2025 is influencing both upstream manufacturing and downstream equipment procurement. Companies are rapidly diversifying sourcing of key components, adopting modular open platforms, and establishing regional partnerships to absorb revenue volatility and ensure reliable access to critical ERCP systems. Healthcare providers face new planning challenges for capital budgets and contract renewals, motivating revised inventory and assembly approaches throughout the supply chain.

Methodology & Data Sources

Findings draw on primary interviews with clinicians, procurement leaders, and industry stakeholders, reinforced by secondary research from peer-reviewed journals, device clearance databases, and regulatory filings. Rigorous segmentation utilized structured frameworks and scenario modeling to evaluate both technology adoption and cost exposure.

Why This Report Matters: Actionable Value for Leadership

  • Equips senior leaders with a rigorous, detail-driven assessment of evolving ERCP technology, care models, and regulatory impacts.
  • Provides segment-specific intelligence to support strategic sourcing, capital planning, and R&D prioritization.
  • Enables competitive benchmarking against both regional and global best practices in procedural innovation and patient outcome management.

Conclusion

The ERCP market is transforming through procedural innovation, modular technology, and proactive supply chain strategies. Stakeholders who align technology investment and agile operational models will secure clinical, financial, and competitive advantages as the market continues to advance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of single-use disposable duodenoscopes to mitigate cross-contamination risks
5.2. Increased utilization of advanced digital cholangioscopy platforms for targeted biliary interventions
5.3. Advancements in artificial intelligence driven image analysis for real-time lesion detection during ERCP
5.4. Development of atraumatic guidewire systems to improve cannulation success rates in complex anatomy
5.5. Rising demand for hybrid ERCP endoscopic ultrasound procedures to combine diagnosis and therapy in single session
5.6. Expansion of training simulation modules incorporating augmented reality to expedite ERCP proficiency acquisition
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Endoscopic Retrograde Cholangiopancreatography Market, by Procedure Type
8.1. Introduction
8.2. Diagnostic
8.2.1. Cholangiography
8.2.2. Pancreatography
8.3. Therapeutic
8.3.1. Sphincterotomy
8.3.2. Stent Placement
8.3.3. Stone Extraction
9. Endoscopic Retrograde Cholangiopancreatography Market, by Product
9.1. Introduction
9.2. Accessories
9.3. Endoscope Systems
9.4. Imaging Systems
9.4.1. Light Sources
9.4.2. Video Processors
10. Endoscopic Retrograde Cholangiopancreatography Market, by Application
10.1. Introduction
10.2. Biliary System Disorders
10.2.1. Gallstones
10.2.2. Leaks
10.2.3. Strictures
10.3. Pancreatic System Disorders
10.3.1. Pancreatitis
10.3.2. Tumors
11. Endoscopic Retrograde Cholangiopancreatography Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Specialty Clinics
12. Americas Endoscopic Retrograde Cholangiopancreatography Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Olympus Corporation
15.3.2. Boston Scientific Corporation
15.3.3. Medtronic plc
15.3.4. Fujifilm Holdings Corporation
15.3.5. HOYA Corporation
15.3.6. KARL STORZ SE & Co. KG
15.3.7. Cook Medical LLC
15.3.8. CONMED Corporation
15.3.9. Ambu A/S
15.3.10. Stryker Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: RESEARCHAI
FIGURE 24. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: RESEARCHSTATISTICS
FIGURE 25. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: RESEARCHCONTACTS
FIGURE 26. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CHOLANGIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CHOLANGIOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SPHINCTEROTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SPHINCTEROTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STENT PLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STENT PLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STONE EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STONE EXTRACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOSCOPE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOSCOPE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY VIDEO PROCESSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY VIDEO PROCESSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY GALLSTONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY GALLSTONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY LEAKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY LEAKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STRICTURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STRICTURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 114. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 115. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 116. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 117. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 118. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 119. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 120. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 121. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 124. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 125. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 126. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 127. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 145. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 222. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 223. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 224. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 225. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 226. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 227. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 228. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 229. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 230. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 231. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 234. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 235. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 236. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 237. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 240. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 241. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 242. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 243. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 244. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 245. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 246. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 247. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 248. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 249. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 252. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 253. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2018-2024 (USD MILLION)
TABLE 254. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SYSTEM DISORDERS, 2025-2030 (USD MILLION)
TABLE 255. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA ENDOSCOPIC RETROGRADE

Samples

Sample File DOWNLOAD NOW

Companies Mentioned

The companies profiled in this Endoscopic Retrograde Cholangiopancreatography market report include:
  • Olympus Corporation
  • Boston Scientific Corporation
  • Medtronic plc
  • Fujifilm Holdings Corporation
  • HOYA Corporation
  • KARL STORZ SE & Co. KG
  • Cook Medical LLC
  • CONMED Corporation
  • Ambu A/S
  • Stryker Corporation

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.21 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.2 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Endoscopic Retrograde Cholangiopancreatography Market Size, Share & Trends Analysis Report By Product (Endoscopes, Endotherapy Devices), By Procedure (Biliary Sphincterotomy, Biliary Stenting), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Endoscopic Retrograde Cholangiopancreatography Market Size, Share & Trends Analysis Report By Product (Endoscopes, Endotherapy Devices), By Procedure (Biliary Sphincterotomy, Biliary Stenting), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
EUR$5,950USDGBP
Endoscopic Retrograde Cholangiopancreatography - Global Strategic Business Report - Product Image

Endoscopic Retrograde Cholangiopancreatography - Global Strategic Business Report

  • Report
  • 183 Pages
  • Global
From
EUR$5,850USDGBP
Endoscopic Retrograde Cholangiopancreatography Market Report by Product, Procedure, End User, and Region 2025-2033 - Product Image

Endoscopic Retrograde Cholangiopancreatography Market Report by Product, Procedure, End User, and Region 2025-2033

  • Report
  • 148 Pages
  • Global
From
EUR$2,999USDGBP
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Report 2025 - Product Image

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Report 2025

  • Report
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Endoscopic Retrograde Cholangiopancreatography Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Endoscopic Retrograde Cholangiopancreatography Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
EUR$4,500USDGBP

About the Endoscopic Retrograde Cholangiopancreatography Market

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a minimally invasive procedure used to diagnose and treat conditions of the biliary and pancreatic ducts. It is often used to diagnose and treat gallstones, bile duct strictures, and pancreatic cancer. During the procedure, a thin, flexible tube with a camera and light is inserted through the mouth and into the small intestine. The camera is used to view the biliary and pancreatic ducts, and a stent may be placed to open a blocked duct. Stents are used in ERCP to open blocked bile and pancreatic ducts. They are typically made of metal or plastic and are inserted into the ducts to keep them open. Stents can be used to treat bile duct strictures, pancreatic cancer, and gallstones. They can also be used to relieve pain and improve the flow of bile and pancreatic juices. Companies in the ERCP stent market include Boston Scientific, Cook Medical, Medtronic, Olympus, and Terumo. These companies manufacture and distribute a variety of stents for use in ERCP procedures. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more